Your browser doesn't support javascript.
loading
Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis.
Schneider-Hohendorf, Tilman; Gerdes, Lisa Ann; Pignolet, Béatrice; Gittelman, Rachel; Ostkamp, Patrick; Rubelt, Florian; Raposo, Catarina; Tackenberg, Björn; Riepenhausen, Marianne; Janoschka, Claudia; Wünsch, Christian; Bucciarelli, Florence; Flierl-Hecht, Andrea; Beltrán, Eduardo; Kümpfel, Tania; Anslinger, Katja; Gross, Catharina C; Chapman, Heidi; Kaplan, Ian; Brassat, David; Wekerle, Hartmut; Kerschensteiner, Martin; Klotz, Luisa; Lünemann, Jan D; Hohlfeld, Reinhard; Liblau, Roland; Wiendl, Heinz; Schwab, Nicholas.
Affiliation
  • Schneider-Hohendorf T; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
  • Gerdes LA; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians Universität München, Munich, Germany.
  • Pignolet B; Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Martinsried, Germany.
  • Gittelman R; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.
  • Ostkamp P; Toulouse Institute for infectious and inflammatory diseases (Infinity), University of Toulouse, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Université Paul Sabatier, Toulouse, France.
  • Rubelt F; Adaptive Biotechnologies, Seattle, WA.
  • Raposo C; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
  • Tackenberg B; Roche Sequencing Solutions, Pleasanton, CA.
  • Riepenhausen M; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Janoschka C; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Wünsch C; Philipps-University, Department of Neurology, Marburg, Germany.
  • Bucciarelli F; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
  • Flierl-Hecht A; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
  • Beltrán E; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
  • Kümpfel T; Toulouse Institute for infectious and inflammatory diseases (Infinity), University of Toulouse, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Université Paul Sabatier, Toulouse, France.
  • Anslinger K; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians Universität München, Munich, Germany.
  • Gross CC; Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Martinsried, Germany.
  • Chapman H; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.
  • Kaplan I; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians Universität München, Munich, Germany.
  • Brassat D; Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Martinsried, Germany.
  • Wekerle H; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.
  • Kerschensteiner M; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians Universität München, Munich, Germany.
  • Klotz L; Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Martinsried, Germany.
  • Lünemann JD; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.
  • Hohlfeld R; Institute of Legal Medicine, Ludwig-Maximilians Universität München, Munich, Germany.
  • Liblau R; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
  • Wiendl H; Adaptive Biotechnologies, Seattle, WA.
  • Schwab N; Adaptive Biotechnologies, Seattle, WA.
J Exp Med ; 219(11)2022 11 07.
Article in En | MEDLINE | ID: mdl-36048016
ABSTRACT
Epstein-Barr virus (EBV) infection precedes multiple sclerosis (MS) pathology and cross-reactive antibodies might link EBV infection to CNS autoimmunity. As an altered anti-EBV T cell reaction was suggested in MS, we queried peripheral blood T cell receptor ß chain (TCRß) repertoires of 1,395 MS patients, 887 controls, and 35 monozygotic, MS-discordant twin pairs for multimer-confirmed, viral antigen-specific TCRß sequences. We detected more MHC-I-restricted EBV-specific TCRß sequences in MS patients. Differences in genetics or upbringing could be excluded by validation in monozygotic twin pairs discordant for MS. Anti-VLA-4 treatment amplified this observation, while interferon ß- or anti-CD20 treatment did not modulate EBV-specific T cell occurrence. In healthy individuals, EBV-specific CD8+ T cells were of an effector-memory phenotype in peripheral blood and cerebrospinal fluid. In MS patients, cerebrospinal fluid also contained EBV-specific central-memory CD8+ T cells, suggesting recent priming. Therefore, MS is not only preceded by EBV infection, but also associated with broader EBV-specific TCR repertoires, consistent with an ongoing anti-EBV immune reaction in MS.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epstein-Barr Virus Infections / Multiple Sclerosis Limits: Humans Language: En Journal: J Exp Med Year: 2022 Document type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epstein-Barr Virus Infections / Multiple Sclerosis Limits: Humans Language: En Journal: J Exp Med Year: 2022 Document type: Article Affiliation country: Germany
...